As of June 9, 2025, Harmony Biosciences Holdings Inc (HRMY) reports a Graham Number of 25.54.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Harmony Biosciences Holdings Inc's Graham Number
Over recent years, Harmony Biosciences Holdings Inc's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-12-31 | 25.54 |
| 2023-12-31 | 20.28 |
| 2022-12-31 | 22.34 |
| 2021-12-31 | 6.64 |
This slight upward trend highlights how Harmony Biosciences Holdings Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Harmony Biosciences Holdings Inc's Graham Number to Peers
To better understand Harmony Biosciences Holdings Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Harmony Biosciences Holdings Inc (HRMY) | 25.54 |
| Johnson & Johnson (JNJ) | 62.52 |
| Eli Lilly and Co (LLY) | 61.36 |
| Theravance Biopharma Inc (TBPH) | 59.12 |
| Merck & Co Inc (MRK) | 53.19 |
| Catalent Inc (CTLT) | 40.60 |
Compared to its competitors, Harmony Biosciences Holdings Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.